← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2000Last known activity
Jan 1, 2022
Timeline
1980s
- Jan 1, 1989
Trans Tasman Radiation Oncology Group— Founded
Drugs by trial phase (41 distinct, 27 trials)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Central Nervous System Neoplasms
- Deglutition Disorders
- Esophageal Neoplasms
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, Follicular
- Neoplasm Metastasis
- Nervous System Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Rectal Neoplasms
- Skin Neoplasms
- Spinal Cord Compression
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
Recent trials (30)
- NCT05796089Lead sponsorPhase 2Jan 1, 2022
- NCT04319783Lead sponsorPhase 2Jan 31, 2021
- NCT04089150CollaboratorPhase 2Sep 30, 2019
- NCT03497767Lead sponsorPhase 2Aug 31, 2018
- NCT03464942CollaboratorPhase 2Apr 30, 2018
- NCT02446444CollaboratorPhase 3Mar 1, 2014
- NCT01855451Lead sponsorPhase 3Jun 1, 2013
- NCT01013779Study chairPhase 2Dec 1, 2009
- NCT01013779Lead sponsorPhase 2Dec 1, 2009
- NCT01013805Lead sponsorPhase 2Nov 1, 2009
- NCT01013805Study chairPhase 2Nov 1, 2009
- NCT00887380Study chairPhase 3Sep 1, 2009
- NCT01924819CollaboratorPhase 2/Phase 3Sep 1, 2009
- NCT00887380Lead sponsorPhase 3Sep 1, 2009
- NCT00704639Lead sponsorPhase 1/Phase 2Apr 1, 2008
Details
- Founded
- Waratah, AU Jan 1, 1989
- Last known activity
- Jan 1, 2022